Patents by Inventor Susan E. Walker

Susan E. Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8752844
    Abstract: A shoe mobility system for allowing a user's shoe to roll on a ground surface while the user is seated in a wheelchair. The system features a base panel connected to a back panel at an angle, wherein the panels are for positioned at the back and bottom area of a shoe. A pair of flanges extends from the back panel of the system, and an axle spans the flanges. A wheel is rotatably attached to the axle. The system is attachable to the user's shoe.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: June 17, 2014
    Inventors: Gregory J. Walker, Susan E. Walker
  • Publication number: 20140066371
    Abstract: The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.
    Type: Application
    Filed: July 19, 2013
    Publication date: March 6, 2014
    Applicant: GlaxoSmithKline
    Inventors: Mark A. BUSH, Jessica E. MATTHEWS, Susan E. WALKER
  • Publication number: 20130005652
    Abstract: The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.
    Type: Application
    Filed: June 12, 2012
    Publication date: January 3, 2013
    Inventors: Mark A. BUSH, Jcssica E. Matthews, Susan E. Walker
  • Patent number: 8338369
    Abstract: The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.
    Type: Grant
    Filed: September 12, 2007
    Date of Patent: December 25, 2012
    Assignee: Glaxosmithkline LLC
    Inventors: Mark A. Bush, Jessica E. Matthews, Susan E. Walker
  • Publication number: 20100009910
    Abstract: The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.
    Type: Application
    Filed: September 12, 2007
    Publication date: January 14, 2010
    Inventors: Mark A. Bush, Jessica E. Matthews, Susan E. Walker